Walking during immunotherapy: a new way to fight breast cancer?

NCT ID NCT07216495

Recruiting now Symptom relief Sponsor: M.D. Anderson Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This pilot study tests whether a supervised treadmill walking program can help people with early-stage triple-negative breast cancer who are receiving immunotherapy before surgery. The main goal is to see if patients can stick with the exercise routine. Researchers will also check if exercise increases immune cells in the blood. The study involves 33 participants and is led by M.D. Anderson Cancer Center.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: supervised aerobic exercise (treadmill walking)
What this could lead to: If it works, this could show that exercise boosts immune cell activity during immunotherapy, potentially improving treatment outcomes.
What could go wrong: This is a very small pilot study (33 people) focused on feasibility, not effectiveness. It may not show clear benefits or be generalizable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AEROBIC EXERCISE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

triple-negative breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AEROBIC EXERCISE EARLY STAGE TRIPLE NEGATIVE BREAST CANCER

Contacts and locations

Locations

MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.